Gordon W. Dewald

Mayo Clinic

Papers

3

Total Citations

317

H-Index

3

About

Gordon W. Dewald is a pioneering cytogeneticist whose work has fundamentally shaped the diagnostic evaluation of both solid tumors and prenatal specimens. His landmark 1989 study, "A cytogenetic study of 53 human gliomas" (247 citations), established the critical role of chromosomal abnormalities in understanding brain tumors, while his subsequent prospective work on cerebral astrocytomas (49 citations) demonstrated that cytogenetic analysis provides independent prognostic value beyond traditional histology—a finding that helped transform cytogenetics from a research tool into a clinical necessity for solid tumor management. Dewald also made significant contributions to prenatal diagnostics, authoring a large-scale prospective study of 4,309 amniotic fluid specimens (21 citations) that refined the definitions of pseudomosaicism, true mosaicism, and maternal cell contamination using robotic harvesting techniques. His work bridges the gap between laboratory innovation and clinical application, providing pathologists and genetic counselors with rigorous frameworks for interpreting complex cytogenetic data. Dewald’s research remains foundational for anyone studying the cytogenetics of gliomas, astrocytomas, or prenatal chromosome analysis.

Research Focus

Key Achievements

3
H-Index
3
Papers
317
Total Citations
106
Avg Citations/Paper
🏆 Most Cited Paper
A cytogenetic study of 53 human gliomas
247 citations · 1989
📈 Most Prolific Year: 1992 (2 Papers)
🤝 Key Collaborators: 11
🏛 Institutions: Mayo Clinic

Top Papers

  1. 1
  2. 2
  3. 3

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago